Search
SynOV1.1
go.drugbank.com/drugs/DB17539InvestigationalSynOV1.1 is under investigation in clinical trial NCT04612504 (Synov1.1 Intratumoral Injection Study). … SynOV1.1 is an investigational cancer immunotherapy developed by SyngenTech.
Rintodestrant
go.drugbank.com/drugs/DB21472InvestigationalRintodestrant is under investigation in clinical trial NCT03455270 (G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer). … Rintodestrant is a small molecule drug.
Linopristin
go.drugbank.com/drugs/DB19296ExperimentalThe combination product was under investigation in clinical trials NCT00653172 and NCT00949130 for treatment of various bacterial infections. … Linopristin is an antibiotic of the streptogramin B class. It is one part of the combination product NXL 103, along with [Virginiamycin M1].
Azilsartan mopivabil
go.drugbank.com/drugs/DB21569ExperimentalThe usage of the INN stem '-sartan' in the name indicates that Azilsartan mopivabil is a angiotensin II receptor antagonist, antihypertensive (non-peptidic). … Azilsartan mopivabil is a small molecule drug.
XmAb24306
go.drugbank.com/drugs/DB17526InvestigationalXmAb24306 is an investigational cancer immunotherapy. It is a heterodimeric interleukin (IL)-15/IL-15-receptor alpha (IL-15Ra) complex fused to a bispecific Fc domain.
Mangostin
go.drugbank.com/drugs/DB14371InvestigationalMangostin is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Pumice
go.drugbank.com/drugs/DB14374InvestigationalPumice is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.